Australian medical research and innovation priorities 2022–2024
Our goal is to provide documents in an accessible format. If you’re having trouble using a document with your accessibility features, please contact us for help.
November 7, 2022
strategy or framework
Following a national consultation, the priorities were developed by the Australian Medical Research Advisory Board (AMRAB) and must be taken into account by the government when making decisions about funding from the MRFF.
AMRAB developed these priorities concurrently with the Australian Medical Research and Innovation Strategy 2021-2026 to align with and facilitate the achievement of the strategy’s vision, objective and strategic objectives. These priorities came into effect on November 6, 2022, replacing the Australian Medical Research and Innovation Priorities 2020-2022, which were in effect until November 5, 2022.
The current MRFF priorities are:
- Consumer Oriented Research
- Research infrastructure and capability
- Translation and Commercialization
- Comparative impact research
- Prevention and Public Health Research
- Primary Care Research
- Capacities and skills of health and medical researchers
- Health of Aboriginal and Torres Strait Islander people
- priority populations
- Antimicrobial Resistance
- global health and health security
- health effects from environmental factors
- Data, digital health and artificial intelligence.